Alterations in GyrA and ParC associated with fluoroquinolone resistance in Enterococcus faecium

被引:51
作者
El Amin, N [1 ]
Jalal, S [1 ]
Wretlind, B [1 ]
机构
[1] Huddinge Univ Hosp, Div Clin & Oral Bacteriol, Dept Immunol Microbiol Pathol & Infect Dis, S-14186 Huddinge, Sweden
关键词
D O I
10.1128/AAC.43.4.947
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
High-level quinolone resistance in Enterococcus faecium was associated with mutations in both gyrA and parC genes in 10 of 11 resistant strains. One low-level resistant strain without such mutations may instead possess an efflux mechanism or alterations in the other subunits of the gyrase or topoisomerase IV genes. These findings are similar to those for other gram-positive bacteria, such as Enterococcus faecalis.
引用
收藏
页码:947 / 949
页数:3
相关论文
共 31 条
  • [1] Susceptibility of ciprofloxacin-resistant staphylococci and enterococci to trovafloxacin
    Bonilla, HF
    Zarins, LT
    Bradley, SF
    Kauffman, CA
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1996, 26 (01) : 17 - 21
  • [2] CHARACTERIZATION OF GLYCOPEPTIDE-RESISTANT ENTEROCOCCI FROM UNITED-STATES HOSPITALS
    CLARK, NC
    COOKSEY, RC
    HILL, BC
    SWENSON, JM
    TENOVER, FC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (11) : 2311 - 2317
  • [3] CLONING AND CHARACTERIZATION OF A DNA GYRASE-A GENE FROM ESCHERICHIA-COLI THAT CONFERS CLINICAL RESISTANCE TO 4-QUINOLONES
    CULLEN, ME
    WYKE, AW
    KURODA, R
    FISHER, LM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (06) : 886 - 894
  • [4] Ericsson HM, 1971, ACTA PATHOL MICROB S, V217, P1
  • [5] Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals
    Everett, MJ
    Jin, YF
    Ricci, V
    Piddock, LJV
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (10) : 2380 - 2386
  • [6] CLONING AND PRIMARY STRUCTURE OF STAPHYLOCOCCUS-AUREUS DNA TOPOISOMERASE-IV - A PRIMARY TARGET OF FLUOROQUINOLONES
    FERRERO, L
    CAMERON, B
    MANSE, B
    LAGNEAUX, D
    CROUZET, J
    FAMECHON, A
    BLANCHE, F
    [J]. MOLECULAR MICROBIOLOGY, 1994, 13 (04) : 641 - 653
  • [7] ANALYSIS OF GYRA AND GRLA MUTATIONS IN STEPWISE-SELECTED CIPROFLOXACIN-RESISTANT MUTANTS OF STAPHYLOCOCCUS-AUREUS
    FERRERO, L
    CAMERON, B
    CROUZET, J
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (07) : 1554 - 1558
  • [8] SEQUENCES OF CONSERVED REGION IN THE A SUBUNIT OF DNA GYRASE FROM 9 SPECIES OF THE GENUS MYCOBACTERIUM - PHYLOGENETIC ANALYSIS AND IMPLICATION FOR INTRINSIC SUSCEPTIBILITY TO QUINOLONES
    GUILLEMIN, I
    CAMBAU, E
    JARLIER, V
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (09) : 2145 - 2149
  • [9] MUTATIONS IN THE GYRA GENE OF A HIGHLY FLUOROQUINOLONE-RESISTANT CLINICAL ISOLATE OF ESCHERICHIA-COLI
    HEISIG, P
    SCHEDLETZKY, H
    FALKENSTEINPAUL, H
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (04) : 696 - 701
  • [10] Intracellular activities of RP 59500 (Quinupristin-Dalfopristin) and sparfloxacin against Enterococcus faecium
    HerreraInsua, I
    JacquesPalaz, K
    Murray, BE
    Rakita, RM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (04) : 886 - 890